Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis. - Wikidata - awgldk - TriplyDB

Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis.

Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis.

http://www.wikidata.org/entity/Q35536251

about

Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis.

http://www.wikidata.org/entity/Q35536251

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Different Finite Durations of ...... omboembolism: A Meta-Analysis.

@ast

Different Finite Durations of ...... omboembolism: A Meta-Analysis.

@en

type

label

Different Finite Durations of ...... omboembolism: A Meta-Analysis.

@ast

Different Finite Durations of ...... omboembolism: A Meta-Analysis.

@en

prefLabel

Different Finite Durations of ...... omboembolism: A Meta-Analysis.

@ast

Different Finite Durations of ...... omboembolism: A Meta-Analysis.

@en

P1433

Q35536251-1AF6AE96-9D38-4AE7-AC45-33E04DE2C032

P1476

Q35536251-FC5E58AF-D951-428A-8652-D194D5EAF8B0

P2093

Q35536251-50FC8821-6A4F-4044-AD16-9A86080142A0

Q35536251-7DA37B5B-F5EB-4C9D-A5C3-D3AC6E4940E4

Q35536251-D1775ACD-C76C-45E9-8187-A06FB75FA59C

Q35536251-D73D88AB-E829-4CE8-8AC2-E45AFEEA8A3D

P2860

Q35536251-0103BD59-DDFF-4D3E-A3FF-77006F72D926

Q35536251-025D3F4B-77F7-458A-A0D1-F2F3BDAFF813

Q35536251-068759B7-8544-4705-86D5-802575EB4E2E

Q35536251-1006DBEA-D0CA-41BF-8FA3-639470D380FB

Q35536251-318D392B-2FDF-4060-B073-3904F7789C12

Q35536251-3E1702C1-552A-41DF-B57E-2BB20818057B

Q35536251-425FDEFC-98E5-4C55-8E14-6F9AE1717284

Q35536251-45B2945E-E7D5-430D-8C80-E33C4450958C

Q35536251-45C4109C-0B28-4426-ABFD-C3A41393D4D3

Q35536251-47FF87A3-8521-4762-AD6D-747D56D8E1B5

P304

Q35536251-176A7B39-C880-4E50-A664-42D7D3966D87

P31

Q35536251-185C00C5-8A00-4E90-B247-243C7385AABF

P356

Q35536251-B8C9C802-DC59-47BC-B542-D39FC0FBBC9C

P478

Q35536251-F8A4588B-A99D-4C7E-B4B1-AC77163FB29C

P577

Q35536251-E0B01DDC-7866-48D3-9AF2-7027AA785125

P5875

Q35536251-1ED2D493-F4AC-4609-BE3B-538EA9994D8B

P698

Q35536251-9BB263C6-0559-4B04-A05A-E14D52F255C6

P921

Q35536251-28C4C928-BAC5-41A1-A5F2-6070D03B6B59

Q35536251-A635374E-EFB9-4808-A719-0CD45A1FD0D1

P932

Q35536251-1B387285-3B3F-4E34-863E-D3BF5352C8A8

P356

P1433

P1476

Different Finite Durations of ...... omboembolism: A Meta-Analysis.

@en

P2093

Aaron B Holley

http://www.w3.org/2001/XMLSchema#string

Christopher S King

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Jackson

http://www.w3.org/2001/XMLSchema#string

Lisa K Moores

http://www.w3.org/2001/XMLSchema#string

P2860

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

D-dimer testing to determine the duration of anticoagulation therapy.

Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

The epidemiology of venous thromboembolism.

Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Duration of anticoagulation following venous thromboembolism: a meta-analysis.

P304

540386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/540386

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51799472

http://www.w3.org/2001/XMLSchema#string

P698

22084660

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

anticoagulation

P932

3211079

http://www.w3.org/2001/XMLSchema#string